Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication

By
Justin.choi
-
0
21
Scientists developed a medium-throughput drug screening system and identified a small molecule library of 34 of 430 protein kinase inhibitors that were capable of inhibiting SARS-CoV-2 cytopathic effect in human epithelial cells.
[Cell Reports]
Garcia, G., Sharma, A., Ramaiah, A., Sen, C., Purkayastha, A., Kohn, D. B., Parcells, M. S., Beck, S., Kim, H., Bakowski, M. A., Kirkpatrick, M. G., Riva, L., Wolff, K. C., Han, B., Yuen, C., Ulmert, D., Purbey, P. K., Scumpia, P., Beutler, N., … Arumugaswami, V. (2021). Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2021.108940 Cite
AbstractGraphical Abstract